| SC 13G/A | 2016-02-16 | SCOPIA CAPITAL MANAGEMENT LP | Aegerion Pharmaceuticals, Inc. | 5,703,587 | 19.7% | EDGAR |
| SC 13G/A | 2016-02-12 | FMR LLC | Aegerion Pharmaceuticals, Inc. | 4,281,264 | 14.8% | EDGAR |
| SC 13G/A | 2016-02-12 | STONEPINE CAPITAL, L.P. | Aegerion Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-10 | BlackRock Inc. | Aegerion Pharmaceuticals, Inc. | 2,512,675 | 8.7% | EDGAR |
| SC 13G/A | 2016-02-10 | VANGUARD GROUP INC | Aegerion Pharmaceuticals, Inc. | 1,974,744 | 6.8% | EDGAR |
| SC 13G/A | 2016-02-05 | WESTFIELD CAPITAL MANAGEMENT CO LP | Aegerion Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-01-11 | PUTNAM INVESTMENTS LLC | Aegerion Pharmaceuticals, Inc. | 1,588,215 | 5.5% | EDGAR |
| SC 13G/A | 2016-01-05 | INTEGRATED CORE STRATEGIES (US) LLC | Aegerion Pharmaceuticals, Inc. | 1,392,697 | 4.8% | EDGAR |
| SC 13G/A | 2015-11-13 | Broadfin Capital, LLC | Aegerion Pharmaceuticals, Inc. | 4,010,291 | 13.6% | EDGAR |
| SC 13D/A | 2015-10-23 | Sarissa Capital Management LP | Aegerion Pharmaceuticals, Inc. | - | - | EDGAR |
| SC 13D/A | 2015-09-29 | Sarissa Capital Management LP | Aegerion Pharmaceuticals, Inc. | 2,355,000 | 8.2% | EDGAR |
| SC 13G | 2015-05-29 | STONEPINE CAPITAL, L.P. | Aegerion Pharmaceuticals, Inc. | 1,500,000 | 5.2% | EDGAR |
| SC 13D/A | 2015-05-21 | Sarissa Capital Management LP | Aegerion Pharmaceuticals, Inc. | 2,019,685 | 7.1% | EDGAR |
| SC 13D/A | 2015-04-01 | Sarissa Capital Management LP | Aegerion Pharmaceuticals, Inc. | - | - | EDGAR |
| SC 13G/A | 2015-02-17 | SCOPIA CAPITAL MANAGEMENT LP | Aegerion Pharmaceuticals, Inc. | 5,349,840 | 18.8% | EDGAR |
| SC 13G/A | 2015-02-17 | Point72 Asset Management, L.P. | Aegerion Pharmaceuticals, Inc. | 1,854,600 | 6.5% | EDGAR |
| SC 13G/A | 2015-02-17 | Broadfin Capital, LLC | Aegerion Pharmaceuticals, Inc. | 2,548,863 | 9.0% | EDGAR |
| SC 13G/A | 2015-02-17 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Aegerion Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2015-02-17 | PUTNAM INVESTMENTS LLC | Aegerion Pharmaceuticals, Inc. | 3,049,607 | 10.7% | EDGAR |
| SC 13G/A | 2015-02-13 | FMR LLC | Aegerion Pharmaceuticals, Inc. | 3,429,628 | 12.1% | EDGAR |